StockData
CVS HEALTH Corp logo

CVS HEALTH Corp (CVS) stock

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3012% above fair value
$85.81−2.78 (-3.14%)

Close on Nov 17, 2026Market cap $109.75BP/E 22.8Yield 3.10%

Cvs Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Cvs Health's revenue for the twelve months ending Jun 30, 2026 was $415.09B, up 7.4% year over year. For fiscal 2025 it was $402.07B, up 7.8% from the year before. Over ten years it grew 10.1% a year on average. The highest annual figure on record is $402.07B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$402.07B+7.8%
FY2024Dec 31, 2024$372.81B+4.2%
FY2023Dec 31, 2023$357.78B+10.9%
FY2022Dec 31, 2022$322.47B+10.4%
FY2021Dec 31, 2021$292.11B+8.7%
FY2020Dec 31, 2020$268.71B+4.6%
FY2019Dec 31, 2019$256.78B+32.0%
FY2018Dec 31, 2018$194.58B+5.3%
FY2017Dec 31, 2017$184.79B+4.1%
FY2016Dec 31, 2016$177.55B+15.8%
FY2015Dec 31, 2015$153.29B+10.0%
FY2014Dec 31, 2014$139.37B+9.9%
FY2013Dec 31, 2013$126.76B+3.0%
FY2012Dec 31, 2012$123.12B+15.0%
FY2011Dec 31, 2011$107.08B+11.8%
FY2010Dec 31, 2010$95.78B-2.5%
FY2009Dec 31, 2009$98.22B+12.3%
FY2008Dec 31, 2008$87.47B+14.6%
FY2007Dec 29, 2007$76.33B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$106.10B+7.3%
Q1 FY2026Mar 31, 2026$100.43B+6.2%
Q4 FY2025Dec 31, 2025$105.69B+8.2%
Q3 FY2025Sep 30, 2025$102.87B+7.8%
Q2 FY2025Jun 30, 2025$98.92B+8.4%
Q1 FY2025Mar 31, 2025$94.59B+7.0%
Q4 FY2024Dec 31, 2024$97.71B+4.2%
Q3 FY2024Sep 30, 2024$95.43B+6.3%
Q2 FY2024Jun 30, 2024$91.23B+2.6%
Q1 FY2024Mar 31, 2024$88.44B+3.7%
Q4 FY2023Dec 31, 2023$93.81B+11.9%
Q3 FY2023Sep 30, 2023$89.76B+10.6%
Q2 FY2023Jun 30, 2023$88.92B+10.3%
Q1 FY2023Mar 31, 2023$85.28B+11.0%
Q4 FY2022Dec 31, 2022$83.85B+9.5%
Q3 FY2022Sep 30, 2022$81.16B+10.0%
Q2 FY2022Jun 30, 2022$80.64B+11.0%
Q1 FY2022Mar 31, 2022$76.83B+11.2%
Q4 FY2021Dec 31, 2021$76.60B+10.1%
Q3 FY2021Sep 30, 2021$73.79B+10.0%
Q2 FY2021Jun 30, 2021$72.62B+11.1%
Q1 FY2021Mar 31, 2021$69.10B+3.5%
Q4 FY2020Dec 31, 2020$69.55B+4.0%
Q3 FY2020Sep 30, 2020$67.06B+3.5%
Q2 FY2020Jun 30, 2020$65.34B+3.0%
Q1 FY2020Mar 31, 2020$66.76B+8.3%
Q4 FY2019Dec 31, 2019$66.89B+22.9%
Q3 FY2019Sep 30, 2019$64.81B+36.5%
Q2 FY2019Jun 30, 2019$63.43B+35.2%
Q1 FY2019Mar 31, 2019$61.65B+34.8%
Q4 FY2018Dec 31, 2018$54.42B+12.5%
Q3 FY2018Sep 30, 2018$47.49B+2.8%
Q2 FY2018Jun 30, 2018$46.92B+2.7%
Q1 FY2018Mar 31, 2018$45.74B+2.7%
Q4 FY2017Dec 31, 2017$48.39B+5.3%
Q3 FY2017Sep 30, 2017$46.19B+3.5%
Q2 FY2017Jun 30, 2017$45.69B–
Q1 FY2017Mar 31, 2017$44.52B–
Q4 FY2016Dec 31, 2016$45.97B–
Q3 FY2016Sep 30, 2016$44.62B–

More Cvs Health figures

See a number that looks wrong?